Rhumbline Advisers Applied Therapeutics Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 133,347 shares of APLT stock, worth $117,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,347
Previous 133,895
0.41%
Holding current value
$117,345
Previous $625,000
81.28%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$9.28 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$8.72 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$8.65 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$7.04 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$5.98 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $42.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...